US Stock MarketDetailed Quotes

PEPG PepGen

Watchlist
  • 11.500
  • -1.090-8.66%
Close Apr 17 16:00 ET
372.08MMarket Cap-3484P/E (TTM)

About PepGen Company

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

Company Profile

SymbolPEPG
Company NamePepGen
Listing DateMay 6, 2022
Issue Price12.00
Founded2018
CEOMr. James McArthur
MarketNASDAQ
Employees64
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address321 Harrison Avenue,8th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-781-797-0979
Websitehttp://pepgen.com

Company Executives

  • Name
  • Position
  • Salary
  • James McArthur
  • President, Chief Executive Officer and Director
  • 4.51M
  • Noel Donnelly
  • Chief Financial Officer and Principal Accounting Officer
  • 1.98M
  • Dr. Jaya Goyal
  • Executive Vice President, Research and Preclinical Development
  • --
  • Dr. Niels Svenstrup
  • Senior Vice President, Chemistry, Manufacturing and Control
  • 1.32M
  • Dr. Michelle L. Mellion
  • Senior Vice President, Clinical Development
  • --
  • Laurie B. Keating, J.D.
  • Chairman of the Board
  • 101.77K
  • Dr. Howard Mayer, M.D.
  • Director
  • --
  • Heidi Henson, C.P.A.
  • Independent Director
  • 125.80K
  • Habib J. Dable
  • Independent Director
  • 147.18K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg